Amerise Biosciences Ltd

Amerise Biosciences Annual General Meeting

Amerise Biosciences Limited conducted its 41st Annual General Meeting on September 24, 2026. Shareholders approved financial statements and the appointment of a new Wholetime Director and CFO.

Amerise Biosciences Annual Report

Amerise Biosciences has submitted its Annual Report for the financial year 2024-25. The company scheduled its 41st Annual General Meeting for September 24, 2026.

Amerise Biosciences Annual General Meeting

Amerise Biosciences Ltd has submitted the notice for its 41st Annual General Meeting, scheduled to be held on September 24, 2026.

Amerise Biosciences Capital Structure Change

Snehjeev Ventures Private Limited and PACs acquired 76,725 equity shares of Amerise Biosciences Ltd. The acquisition increases their aggregate stake from 10.92% to 11.04%.

Amerise Biosciences Management Change

Amerise Biosciences Limited has appointed Ms. Soni Pandiya as the new Company Secretary, replacing Ms. Minal Lakhani who resigned for better career opportunities.

Amerise Biosciences Q1 FY27 Results: Net Loss of ₹0.1 Cr

Amerise Biosciences Ltd reported a net loss of ₹0.1 Cr for Q1 FY27.

Key figure

Net loss ₹0.1 Cr

Amerise Biosciences Capital Structure Change

Snehjeev Ventures Pvt. Ltd. and PACs increased their stake in Amerise Biosciences Ltd by 0.04% through an open market purchase, reaching 9.02% total holding.

Amerise Biosciences Board Meeting Date

Amerise Biosciences Ltd has scheduled a Board Meeting on 3rd August 2026 to consider and approve the un-audited financial results for the quarter ended 30th June 2026.

Amerise Biosciences Capital Structure Change

Snehjeev Ventures Private Limited sold 3,18,285 shares of Amerise Biosciences in the open market. Their holding reduced from 9.31% to 8.83%.

Amerise Biosciences Capital Structure Change

Snehjeev Ventures Pvt Ltd acquired a 0.06% stake in Amerise Biosciences via open market. This increases their total holding to 9.04% of the company.